Blog - Page 1038 of 5757

WednesdayMay 11, 2022 1:12 pm

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Expanding Reach, Reports ‘Significant Balance Sheet and Operational Improvements’

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF) has been strengthening its revenue streams in the states where it operates, particularly in Michigan, Florida and California of late, while also working to deal with its debt to make it more long-term feasible, announcing recently that it has eliminated several million dollars’ worth of liabilities and annual expenses. “The acquisition earlier this year of a 15,000-square-foot manufacturing, processing and distribution facility as well as properties owned by PharmaCo Inc., in Michigan, plus full licensing for manufacturing both medical and adult-use cannabis products in the state, assured RWB’s efforts to become fully…

WednesdayMay 11, 2022 12:43 pm

QualityStocksNewsBreaks – Kronos Advanced Technologies Inc. (KNOS) Looking to Develop, Support Disruptive Manufacturing Methods and Graphene-Based Futuristic Products

Kronos Advanced Technologies (OTC: KNOS) is the exclusive national distributor of a revolutionary new air-purification device engineered for personal space protection. “The ViralWall(TM) is designed to be placed between individuals, draw in their exhaled air, kill or disable pathogens as they move through the patented graphene-based air filter, and then release disinfected pathogen-free air. The first-ever self-sterilizing graphene air purifier on the market, the ViralWall was developed by Israel-based R&D company LIGC Application Limited… ‘The graphene air filters will be more efficient, cost-effective, consume less energy, and require far less maintenance than other air filters currently on the market,’ said…

WednesdayMay 11, 2022 12:34 pm

QualityStocksNewsBreaks – Nowigence Inc. Recognized for Demonstrating ‘Deep Insight’ into New Market Fundamentals

Nowigence was named as one of the finalists in the KPMG Private Enterprise’s Global Tech Innovator competition, which was designed to identify innovators in the United States that have the potential to become the next tech titans on the global stage. The contest recognized companies that show “deep insight” into new market fundamentals, and KPMG Private Enterprise noted that 10 finalists were invited to deliver their final pitches to a panel of industry experts. “Nowigence Inc. was one of those companies. Nowigence is emerging in the AI software space as a top innovative contender with its proprietary offering, Pluaris. The…

WednesdayMay 11, 2022 12:00 pm

Alternative Products Expo At Medellin, Colombia, To Promote The Local Business Community

Alternative Products Expo is coming to Medellín, Colombia, on May 21-22nd 2022. A leading organizer in the alternative industry, they’re committed to serving the community and strive to provide an exciting learning experience in a safe and conducive environment. For one, exhibitors can showcase their products, expand their market reach, and get discovered by investors and industry professionals. Sponsored by JuicyFields.io, this event is expecting 100+ vendors and 1000+ products, including other sponsoring brands such as LightFire & EZ Delta 8 Wholesale. A one-of-a-kind networking event, at Alt Pro Expo, buyers and investors seeking profitable avenues can discover some of…

WednesdayMay 11, 2022 11:17 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at H.C. Wainwright Global Investment Conference

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that its CEO Doug Drysdale will participate in a fireside chat at the H.C. Wainwright Global Investment Hybrid Conference. The event is taking place May 23-26, 2022, at the Fontainebleau Miami Beach. Drysdale’s fireside chat will be webcast live at 12:30 p.m. ET on Wednesday, May 25. Interested parties should visit https://ibn.fm/0nlvQ to register and access the live webcast. An archived version of the webcast will also be available on the company’s investor relations website. To view the full press release, visit https://ibn.fm/95cUd…

WednesdayMay 11, 2022 11:15 am

Silo Pharma Inc. (SILO) Spotlight: Ketamine

Ketamine shows promise in treating Alzheimer’s Disease, Parkinson’s Disease as well as depression, suicide ideation and more In 2021, Silo Pharma (OTCQB: SILO) entered into a joint venture with Zylö Therapeutics to “explore the clinical development of ketamine using ZTI’s Z-pod (transdermal) technology.” This innovative technology allows Silo, an early-stage biopharmaceutical company, to develop a ketamine delivery system for those suffering dysphagia, a difficulty or complete inability to swallow.(1) Silo Pharma is exploring the efficacy of ketamine in treating patients suffering from both Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”). Over 80% of PD patients(2) and 75% of AD patients(3)…

WednesdayMay 11, 2022 11:02 am

QualityStocksNewsBreaks – Eat Well Investment Group Inc.’s (CSE: EWG) (OTC: EWGFF) Amara Organic Foods Makes List of Top-Five Direct-to-Consumer Brands

Eat Well Group (CSE: EWG) (OTC: EWGFF), a publicly traded investment company, has announced that Amara Organic Foods, one of its investee companies, has been named no. 5 on Business Insider’s fastest-growing direct-to-consumer brands. In addition to that, Amara also earned a spot on Good Housekeeping’s list of best organic baby foods for 2022. The Business Insider ranking was based on Similarweb data, including monthly traffic and Q1 growth across several different categories, such as food, personal care, and health. According to the announcement, Amara’s average monthly website visits reached visits almost 40,000 with quarter-over-quarter web-traffic growth of 286%. The…

WednesdayMay 11, 2022 10:30 am

Investor Event Turns Spotlight on Novel Brain Cancer Drug Candidate Global Trial Under Way by CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)

CNS Pharmaceuticals is developing a proprietary drug candidate that has the potential to deliver a novel solution for unmet medical needs in treating an incurable brain cancer CNS’s drug candidate is called Berubicin, a powerful anthracycline that appears to be the first such chemotherapy agent able to successfully cross the blood-brain barrier Berubicin dosing has begun in a potentially pivotal global trial that is recruiting glioblastoma multiforme (“GBM”) brain cancer patients The FDA has granted CNS fast-track authorization in regard to Berubicin’s development, and European countries’ drug regulatory bodies are also granting authorization to advance the trial process there An…

WednesdayMay 11, 2022 9:45 am

Friendable Inc. (FDBL) Provides Independent Artists 360 Anti-Label Platform for Music Creation, Distribution, and Promotion

Fan Pass Live with Artist Republik and FeaturedX is creating a 360 platform with pricing that sets them apart from competitors The May contest on Instagram is underway, and features Grow with Us (“GWU”) campaigns to help artists build their fanbase on Spotify/Soundcloud In the first 100 days, positive growth has been reflected across revenue per subscriber, spend per customer, and subscriber lifetime value Key metrics for social media have also seen an increase across the board In the five months since announcing the acquisition of Artist Republik (and FeaturedX), Friendable (OTC: FDBL), and its flagship offering, Fan Pass Live…

WednesdayMay 11, 2022 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Technology Influencing the Pharmaceutical Industry

Lexaria began its human clinical study on oral nicotine alternatives, evaluating the effectiveness of its DehydraTECH-nicotine pouch performance Earlier in the year, the company also announced the commencement of its HYPER-H21-4 human clinical study on the effectiveness of DehydraTECH-processed CBD for hypertension treatment Lexaria has also made some significant progress in the use of its technology for the enhanced delivery of antiviral drugs It hopes that before the end of 2022, it will have built sufficient data to effect meaningful industry progress and sustainable increases in valuation Lexaria Bioscience (NASDAQ: LEXX), since its inception, has been pushing the boundaries of…

Site Search

Company Search